Molecular Formula | C24H16F3NO4 |
Molar Mass | 439.38 |
Density | 1.34 |
Melting Point | 164-167℃ |
Solubility | DMSO (Sparingly), Methanol (Slightly) |
Appearance | powder |
Color | white to beige |
Storage Condition | -20°C |
In vitro study | In a panel of human bladder cancer cell lines, PAI-1 reduced cell proliferation, cell adhesion, and colony formation, and induced apoptosis and anodyne apoptosis. |
In vivo study | In a rat carotid artery thrombosis model, Tiplaxtinin (1 mg/kg, p.o.) increases the time to occlusion and prevents a decrease in carotid artery blood flow. In C57BL/6J mice, Tiplaxtinin(1 mg/g food) attenuated Ang II-induced aortic remodeling. Tiplaxtinin (p.o.) restores skeletal muscle regeneration in untreated type 1 diabetic mice. In athymic mice bearing human cancer cell lines T24 and HeLa xenografts, Tiplaxtinin (1 mg/kg, p. Et al. o.) decreased tumor xenograft growth is associated with decreased tumor angiogenesis, decreased cell proliferation, and increased apoptosis. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.276 ml | 11.38 ml | 22.759 ml |
5 mM | 0.455 ml | 2.276 ml | 4.552 ml |
10 mM | 0.228 ml | 1.138 ml | 2.276 ml |
5 mM | 0.046 ml | 0.228 ml | 0.455 ml |